Amylin Pharmaceuticals
| Use attributes for filter ! | |
| Headquarters | San Diego |
|---|---|
| California | |
| United States | |
| Founded | San Diego |
| California | |
| United States | |
| Defunct | 2012 |
| Number of employees | 1,300 (2011) |
| Parent organizations | AstraZeneca |
| Subsidiaries | Amylin Ohio LLC |
| Amylin Europe ltd | |
| Amylin Investments LLC | |
| Amylin Puerto Rico LLC | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844692 |
About Amylin Pharmaceuticals
Amylin Pharmaceuticals was a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin, Byetta and Bydureon.
